Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001193125-25-198845
Filing Date
2025-09-09
Accepted
2025-09-09 08:17:08
Documents
5

Document Format Files

Seq Description Document Type Size
1 SC14D9C d10286dsc14d9c.htm SC14D9C 26063
2 EX-99.2 d10286dex992.htm EX-99.2 14406
3 EX-99.3 d10286dex993.htm EX-99.3 40444
4 EX-99.4 d10286dex994.htm EX-99.4 13512
5 EX-99.5 d10286dex995.htm EX-99.5 13927
  Complete submission text file 0001193125-25-198845.txt   110263
Mailing Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010
Business Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010 646-481-9832
Tourmaline Bio, Inc. (Filed by) CIK: 0001827506 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010
Business Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010 646-481-9832
Tourmaline Bio, Inc. (Subject) CIK: 0001827506 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C | Act: 34 | File No.: 005-92543 | Film No.: 251301744
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)